These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 18778390

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Withdrawal symptoms as a predictor of mortality in patients HIV-infected through drug use and receiving highly active antiretroviral therapy (HAART).
    Michel L, Giorgi R, Villes V, Poizot-Martin I, Dellamonica P, Spire B, Protopopescu C, Carrieri MP.
    Drug Alcohol Depend; 2009 Jan 01; 99(1-3):96-104. PubMed ID: 18774237
    [Abstract] [Full Text] [Related]

  • 25. HAART with didanosine once versus twice daily: adherence and efficacy.
    Roca B, Lapuebla C, Vidal-Tegedor B.
    Int J Infect Dis; 2005 Jul 01; 9(4):195-200. PubMed ID: 15964537
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P, Fassino S, Lavagnino L, Orofino G, Morosini P, Picardi A.
    Psychother Psychosom; 2009 Jul 01; 78(4):254-7. PubMed ID: 19468260
    [Abstract] [Full Text] [Related]

  • 28. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.
    Park WB, Choe PG, Kim SH, Jo JH, Bang JH, Kim HB, Kim NJ, Oh M, Choe KW.
    J Intern Med; 2007 Mar 01; 261(3):268-75. PubMed ID: 17305649
    [Abstract] [Full Text] [Related]

  • 29. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group.
    Moatti JP, Carrieri MP, Spire B, Gastaut JA, Cassuto JP, Moreau J.
    AIDS; 2000 Jan 28; 14(2):151-5. PubMed ID: 10708285
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.